Antonio Ferrer-Montiel - Publications

Affiliations: 
Institute of Molecular and Cellular Biology Universidad Miguel Hernández de Elche 

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. Targeting thermoTRP ion channels: preclinical approaches and opportunities. Expert Opinion On Therapeutic Targets. 1-19. PMID 32972264 DOI: 10.1080/14728222.2020.1820987  0.48
2020 Fernández-Carvajal A, González-Muñiz R, Fernández-Ballester G, Ferrer-Montiel A. Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels. Expert Opinion On Investigational Drugs. PMID 32941080 DOI: 10.1080/13543784.2020.1825680  0.48
2020 Bonache MÁ, Martín-Escura C, de la Torre Martínez R, Medina A, González-Rodríguez S, Francesch A, Cuevas C, Roa AM, Fernández-Ballester G, Ferrer-Montiel A, Fernández-Carvajal A, González-Muñiz R. Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity. Scientific Reports. 10: 14154. PMID 32843690 DOI: 10.1038/s41598-020-70691-x  0.48
2019 Journigan VB, Feng Z, Rahman S, Wang Y, Amin ARMR, Heffner CE, Bachtel N, Wang S, Gonzalez-Rodriguez S, Fernández-Carvajal A, Fernández-Ballester G, Hilton JK, Van Horn WD, Ferrer-Montiel A, Xie XQ, et al. Structure-based design of novel biphenyl amide antagonists of human Transient Receptor Potential Cation Channel Subfamily M Member 8 channels (TRPM8) with potential implications in the treatment of sensory neuropathies. Acs Chemical Neuroscience. PMID 31850745 DOI: 10.1021/acschemneuro.9b00404  0.48
2019 Gonzalez Gil I, Zian D, Vázquez-Villa H, Hernandez-Torres G, Martinez RF, Khiar-Fernandez N, Rivera R, Kihara Y, Devesa I, Mathivanan S, Rosell Del Valle C, Zambrana-Infantes E, Puigdomenech M, Cincilla G, Sanchez-Martinez M, ... ... Ferrer-Montiel A, et al. A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration. Journal of Medicinal Chemistry. PMID 31790581 DOI: 10.1021/acs.jmedchem.9b01287  0.6
2019 Pérez de Vega MJ, Fernández-Mendívil C, de la Torre-Martinez R, González-Rodríguez S, Mulet J, Sala F, Sala S, Criado M, Moreno-Fernandez S, Miguel M, Fernández-Carvajal A, Ferrer-Montiel A, López MG, González-Muñiz R. 1-(2',5'-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A positive allosteric modulator of α7 nicotinic receptors with analgesic and neuroprotective activity. Acs Chemical Neuroscience. PMID 31322853 DOI: 10.1021/acschemneuro.9b00364  0.48
2019 Solé L, Roig SR, Sastre D, Vallejo-Gracia A, Serrano-Albarrás A, Ferrer-Montiel A, Fernández-Ballester G, Tamkun MM, Felipe A. The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801164RR. PMID 30969795 DOI: 10.1096/fj.201801164RR  0.48
2018 Bertamino A, Iraci N, Ostacolo C, Ambrosino P, Musella S, Di Sarno V, Ciaglia T, Pepe G, Sala M, Soldovieri MV, Mosca I, Gonzalez-Rodriguez S, Fernández-Carvajal A, Ferrer-Montiel A, Novellino E, et al. Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity. Journal of Medicinal Chemistry. PMID 29939028 DOI: 10.1021/acs.jmedchem.8b00545  0.48
2018 Serafini M, Griglio A, Aprile S, Seiti F, Travelli C, Pattarino F, Grosa G, Sorba G, Genazzani AA, Gonzales-Rodriguez S, Butron L, Devesa I, Fernández-Carvajal A, Pirali T, Ferrer-Montiel A. Targeting transient receptor potential vanilloid 1 (TRPV1) channel softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. Journal of Medicinal Chemistry. PMID 29722529 DOI: 10.1021/acs.jmedchem.8b00109  0.6
2018 Balsera B, Mulet J, Sala S, Sala F, de la Torre-Martínez R, González-Rodríguez S, Plata A, Naesens L, Fernández-Carvajal A, Ferrer-Montiel A, Criado M, Pérez de Vega MJ, González-Muñiz R. Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity. European Journal of Medicinal Chemistry. 143: 157-165. PMID 29174812 DOI: 10.1016/j.ejmech.2017.10.083  0.48
2017 Quarta S, Camprubí-Robles M, Schweigreiter R, Matusica D, Haberberger RV, Proia RL, Bandtlow CE, Ferrer-Montiel A, Kress M. Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation. Frontiers in Molecular Neuroscience. 10: 317. PMID 29066950 DOI: 10.3389/fnmol.2017.00317  0.32
2017 de la Torre-Martínez R, Bonache MA, Llabrés-Campaner PJ, Balsera B, Fernández-Carvajal A, Fernández-Ballester G, Ferrer-Montiel A, Pérez de Vega MJ, González-Muñiz R. Synthesis, high-throughput screening and pharmacological characterization of β-lactam derivatives as TRPM8 antagonists. Scientific Reports. 7: 10766. PMID 28883526 DOI: 10.1038/s41598-017-10913-x  0.48
2017 Ciardo MG, Ferrer-Montiel A. Lipids as central modulators of sensory TRP channels. Biochimica Et Biophysica Acta. PMID 28432033 DOI: 10.1016/j.bbamem.2017.04.012  1
2016 Mathivanan S, Devesa I, Changeux JP, Ferrer-Montiel A. Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors. Frontiers in Pharmacology. 7: 178. PMID 27445816 DOI: 10.3389/fphar.2016.00178  0.6
2016 Criado M, Balsera B, Mulet J, Sala S, Sala F, la Torre-Martínez R, Fernández-Carvajal A, Ferrer-Montiel A, Moreno-Fernández S, Miguel M, Pérez de Vega MJ, González-Muñiz R. 1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties. Future Medicinal Chemistry. PMID 27161515 DOI: 10.4155/fmc-2015-0001  0.48
2016 Taberner FJ, Devesa I, Ferrer-Montiel A. Calcium Entry Through Thermosensory Channels. Advances in Experimental Medicine and Biology. 898: 265-304. PMID 27161233 DOI: 10.1007/978-3-319-26974-0_12  0.6
2015 Ciardo MG, Andrés-Bordería A, Cuesta N, Valente P, Camprubí-Robles M, Yang J, Planells-Cases R, Ferrer-Montiel A. Whirlin increases TRPV1 channel expression and cellular stability. Biochimica Et Biophysica Acta. PMID 26516054 DOI: 10.1016/j.bbamcr.2015.10.016  1
2015 Caires R, Luis E, Taberner FJ, Fernandez-Ballester G, Ferrer-Montiel A, Balazs EA, Gomis A, Belmonte C, de la Peña E. Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain. Nature Communications. 6: 8095. PMID 26311398 DOI: 10.1038/ncomms9095  0.6
2015 Gregorio-Teruel L, Valente P, Liu B, Fernández-Ballester G, Qin F, Ferrer-Montiel A. The Integrity of the TRP Domain Is Pivotal for Correct TRPV1 Channel Gating. Biophysical Journal. 109: 529-41. PMID 26244735 DOI: 10.1016/j.bpj.2015.06.039  0.48
2015 Taberner FJ, Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. TRP channels interaction with lipids and its implications in disease. Biochimica Et Biophysica Acta. 1848: 1818-27. PMID 25838124 DOI: 10.1016/j.bbamem.2015.03.022  0.6
2014 Devesa I, Ferrándiz-Huertas C, Mathivanan S, Wolf C, Luján R, Changeux JP, Ferrer-Montiel A. αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors. Proceedings of the National Academy of Sciences of the United States of America. 111: 18345-50. PMID 25489075 DOI: 10.1073/pnas.1420252111  0.6
2014 Ferrandiz-Huertas C, Mathivanan S, Wolf CJ, Devesa I, Ferrer-Montiel A. Trafficking of ThermoTRP Channels. Membranes. 4: 525-64. PMID 25257900 DOI: 10.3390/membranes4030525  0.6
2014 Balsera B, Mulet J, Fernández-Carvajal A, de la Torre-Martínez R, Ferrer-Montiel A, Hernández-Jiménez JG, Estévez-Herrera J, Borges R, Freitas AE, López MG, García-López MT, González-Muñiz R, Pérez de Vega MJ, Valor LM, Svobodová L, et al. Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: a new target for a privileged structure. European Journal of Medicinal Chemistry. 86: 724-39. PMID 25232969 DOI: 10.1016/j.ejmech.2014.09.039  0.48
2014 Taberner FJ, López-Córdoba A, Fernández-Ballester G, Korchev Y, Ferrer-Montiel A. The region adjacent to the C-end of the inner gate in transient receptor potential melastatin 8 (TRPM8) channels plays a central role in allosteric channel activation. The Journal of Biological Chemistry. 289: 28579-94. PMID 25157108 DOI: 10.1074/jbc.M114.577478  0.6
2014 Gregorio-Teruel L, Valente P, González-Ros JM, Fernández-Ballester G, Ferrer-Montiel A. Mutation of I696 and W697 in the TRP box of vanilloid receptor subtype I modulates allosteric channel activation. The Journal of General Physiology. 143: 361-75. PMID 24567510 DOI: 10.1085/jgp.201311070  0.48
2014 Devesa I, Ferrer-Montiel A. Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling. The European Journal of Neuroscience. 39: 353-62. PMID 24494676 DOI: 10.1111/ejn.12455  0.6
2013 Martínez-Mármol R, Pérez-Verdaguer M, Roig SR, Vallejo-Gracia A, Gotsi P, Serrano-Albarrás A, Bahamonde MI, Ferrer-Montiel A, Fernández-Ballester G, Comes N, Felipe A. A non-canonical di-acidic signal at the C-terminus of Kv1.3 determines anterograde trafficking and surface expression. Journal of Cell Science. 126: 5681-91. PMID 24144698 DOI: 10.1242/jcs.134825  0.48
2013 Devesa I, Fernández-Ballester G, Ferrer-Montiel A. Targeting protein-protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis. Embo Molecular Medicine. 5: 1462-4. PMID 23983009 DOI: 10.1002/emmm.201303301  0.6
2013 Belghiti M, Estévez-Herrera J, Giménez-Garzó C, González-Usano A, Montoliu C, Ferrer-Montiel A, Felipo V, Planells-Cases R. Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease. The Journal of Biological Chemistry. 288: 9675-85. PMID 23408423 DOI: 10.1074/jbc.M113.455162  0.32
2013 Pérez-Faginas P, Aranda MT, García-López MT, Infantes L, Fernández-Carvajal A, González-Ros JM, Ferrer-Montiel A, González-Muñiz R. Highly functionalized 1,2-diamino compounds through reductive amination of amino acid-derived β-keto esters. Plos One. 8: e53231. PMID 23308167 DOI: 10.1371/journal.pone.0053231  0.48
2012 Ferrer-Montiel A, Fernández-Carvajal A, Planells-Cases R, Fernández-Ballester G, González-Ros JM, Messeguer A, González-Muñiz R. Advances in modulating thermosensory TRP channels. Expert Opinion On Therapeutic Patents. 22: 999-1017. PMID 22835143 DOI: 10.1517/13543776.2012.711320  0.48
2012 Sanz-Salvador L, Andrés-Borderia A, Ferrer-Montiel A, Planells-Cases R. Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. The Journal of Biological Chemistry. 287: 19462-71. PMID 22493457 DOI: 10.1074/jbc.M111.289751  0.32
2012 Navarro A, Encinar JA, López-Méndez B, Aguado-Llera D, Prieto J, Gómez J, Martínez-Cruz LA, Millet O, González-Ros JM, Fernández-Ballester G, Neira JL, Ferrer-Montiel A. Mutation of Ser-50 and Cys-66 in Snapin modulates protein structure and stability. Biochemistry. 51: 3470-84. PMID 22471585 DOI: 10.1021/bi201574t  0.48
2012 Ponsati B, Carreño C, Curto-Reyes V, Valenzuela B, Duart MJ, Van den Nest W, Cauli O, Beltran B, Fernandez J, Borsini F, Caprioli A, Di Serio S, Veretchy M, Baamonde A, Menendez L, ... ... Ferrer-Montiel A, et al. An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics. 341: 634-45. PMID 22393248 DOI: 10.1124/jpet.111.190678  0.32
2011 Fernández-Ballester G, Fernández-Carvajal A, González-Ros JM, Ferrer-Montiel A. Ionic channels as targets for drug design: a review on computational methods. Pharmaceutics. 3: 932-53. PMID 24309315 DOI: 10.3390/pharmaceutics3040932  0.48
2011 Fernández-Carvajal A, Fernández-Ballester G, Devesa I, González-Ros JM, Ferrer-Montiel A. New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view. Pharmaceuticals (Basel, Switzerland). 5: 16-48. PMID 24288041 DOI: 10.3390/ph5010016  0.6
2011 Devesa I, Planells-Cases R, Fernández-Ballester G, González-Ros JM, Ferrer-Montiel A, Fernández-Carvajal A. Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. Journal of Inflammation Research. 4: 67-81. PMID 22096371 DOI: 10.2147/JIR.S12978  0.6
2011 Vidal-Mosquera M, Fernández-Carvajal A, Moure A, Valente P, Planells-Cases R, González-Ros JM, Bujons J, Ferrer-Montiel A, Messeguer A. Triazine-based vanilloid 1 receptor open channel blockers: design, synthesis, evaluation, and SAR analysis. Journal of Medicinal Chemistry. 54: 7441-52. PMID 21950613 DOI: 10.1021/jm200981s  0.48
2011 Gerona-Navarro G, González-Muñiz R, Fernández-Carvajal A, González-Ros JM, Ferrer-Montiel A, Carreño C, Albericio F, Royo M. Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade. Acs Combinatorial Science. 13: 458-65. PMID 21671576 DOI: 10.1021/co1000986  0.48
2011 Goswami C, Kuhn J, Dina OA, Fernández-Ballester G, Levine JD, Ferrer-Montiel A, Hucho T. Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway. Journal of Neurochemistry. 117: 995-1008. PMID 21480900 DOI: 10.1111/j.1471-4159.2011.07270.x  0.48
2011 Valente P, Fernández-Carvajal A, Camprubí-Robles M, Gomis A, Quirce S, Viana F, Fernández-Ballester G, González-Ros JM, Belmonte C, Planells-Cases R, Ferrer-Montiel A. Membrane-tethered peptides patterned after the TRP domain (TRPducins) selectively inhibit TRPV1 channel activity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 1628-40. PMID 21307333 DOI: 10.1096/fj.10-174433  0.48
2011 Planells-Cases R, Valente P, Ferrer-Montiel A, Qin F, Szallasi A. Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. Advances in Experimental Medicine and Biology. 704: 491-515. PMID 21290313 DOI: 10.1007/978-94-007-0265-3_27  0.32
2011 Ferrándiz-Huertas C, Fernández-Carvajal A, Ferrer-Montiel A. Rab4 interacts with the human P-glycoprotein and modulates its surface expression in multidrug resistant K562 cells. International Journal of Cancer. 128: 192-205. PMID 20209493 DOI: 10.1002/ijc.25310  0.48
2010 Pérez de Vega MJ, García-López MT, Zaccaro L, Royo M, Albericio F, Fernández-Carvajal A, Ferrer-Montiel A, González-Muñiz R. Solid-phase synthesis of new Trp(Nps)-containing dipeptide derivatives as TRPV1 channel blockers. Molecules (Basel, Switzerland). 15: 4924-33. PMID 20657400 DOI: 10.3390/molecules15074924  0.48
2009 Malkia A, Pertusa M, Fernández-Ballester G, Ferrer-Montiel A, Viana F. Differential role of the menthol-binding residue Y745 in the antagonism of thermally gated TRPM8 channels. Molecular Pain. 5: 62. PMID 19886999 DOI: 10.1186/1744-8069-5-62  0.48
2008 Valente P, García-Sanz N, Gomis A, Fernández-Carvajal A, Fernández-Ballester G, Viana F, Belmonte C, Ferrer-Montiel A. Identification of molecular determinants of channel gating in the transient receptor potential box of vanilloid receptor I. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3298-309. PMID 18559878 DOI: 10.1096/fj.08-107425  0.48
2007 Quintanar-Audelo M, Fernández-Carvajal A, Van Den Nest W, Carreño C, Ferrer-Montiel A, Albericio F. Design and synthesis of indole-based peptoids as potent noncompetitive antagonists of transient receptor potential vanilloid 1. Journal of Medicinal Chemistry. 50: 6133-43. PMID 17985859 DOI: 10.1021/jm070612v  0.48
2007 García-Sanz N, Valente P, Gomis A, Fernández-Carvajal A, Fernández-Ballester G, Viana F, Belmonte C, Ferrer-Montiel A. A role of the transient receptor potential domain of vanilloid receptor I in channel gating. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11641-50. PMID 17959807 DOI: 10.1523/JNEUROSCI.2457-07.2007  0.48
2006 Messeguer A, Planells-Cases R, Ferrer-Montiel A. Physiology and pharmacology of the vanilloid receptor. Current Neuropharmacology. 4: 1-15. PMID 18615132  0.32
2006 Planells-Cases R, Lerma J, Ferrer-Montiel A. Pharmacological intervention at ionotropic glutamate receptor complexes. Current Pharmaceutical Design. 12: 3583-96. PMID 17073661 DOI: 10.2174/138161206778522092  0.32
2005 Planells-Cases R, Garcìa-Sanz N, Morenilla-Palao C, Ferrer-Montiel A. Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Pflugers Archiv : European Journal of Physiology. 451: 151-9. PMID 15909179 DOI: 10.1007/s00424-005-1423-5  0.32
2005 Caprini M, Fava M, Valente P, Fernandez-Ballester G, Rapisarda C, Ferroni S, Ferrer-Montiel A. Molecular compatibility of the channel gate and the N terminus of S5 segment for voltage-gated channel activity. The Journal of Biological Chemistry. 280: 18253-64. PMID 15749711 DOI: 10.1074/jbc.M413389200  0.32
2004 Ibañez C, Blanes-Mira C, Fernández-Ballester G, Planells-Cases R, Ferrer-Montiel A. Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation. Febs Letters. 578: 121-7. PMID 15581628 DOI: 10.1016/j.febslet.2004.10.084  0.32
2004 García-Sanz N, Fernández-Carvajal A, Morenilla-Palao C, Planells-Cases R, Fajardo-Sánchez E, Fernández-Ballester G, Ferrer-Montiel A. Identification of a tetramerization domain in the C terminus of the vanilloid receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5307-14. PMID 15190102 DOI: 10.1523/JNEUROSCI.0202-04.2004  0.48
2004 Ferrer-Montiel A, García-Martínez C, Morenilla-Palao C, García-Sanz N, Fernández-Carvajal A, Fernández-Ballester G, Planells-Cases R. Molecular architecture of the vanilloid receptor. Insights for drug design. European Journal of Biochemistry. 271: 1820-6. PMID 15128292 DOI: 10.1111/j.1432-1033.2004.04083.x  0.48
2004 Morenilla-Palao C, Planells-Cases R, García-Sanz N, Ferrer-Montiel A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. The Journal of Biological Chemistry. 279: 25665-72. PMID 15066994 DOI: 10.1074/jbc.M311515200  0.32
2004 Blanes-Mira C, Merino JM, Valera E, Fernández-Ballester G, Gutiérrez LM, Viniegra S, Pérez-Payá E, Ferrer-Montiel A. Small peptides patterned after the N-terminus domain of SNAP25 inhibit SNARE complex assembly and regulated exocytosis. Journal of Neurochemistry. 88: 124-35. PMID 14675156  0.48
2003 Planells-Cases R, Pérez-Payá E, Messeguer A, Carreño C, Ferrer-Montiel A. Small molecules targeting the NMDA receptor complex as drugs for neuropathic pain. Mini Reviews in Medicinal Chemistry. 3: 749-56. PMID 14529515  0.32
2003 Blanes-Mira C, Pastor MT, Valera E, Fernández-Ballester G, Merino JM, Gutierrez LM, Perez-Payá E, Ferrer-Montiel A. Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library. The Biochemical Journal. 375: 159-66. PMID 12852787 DOI: 10.1042/BJ20030509  0.48
2003 Caprini M, Gomis A, Cabedo H, Planells-Cases R, Belmonte C, Viana F, Ferrer-Montiel A. GAP43 stimulates inositol trisphosphate-mediated calcium release in response to hypotonicity. The Embo Journal. 22: 3004-14. PMID 12805215 DOI: 10.1093/emboj/cdg294  0.32
2002 Valera E, Fernández-Salguero PM, Planells-Cases R, Messeguer A, Van Den Nest W, Carreño C, Ferrer-Montiel A, Merino JM. Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons. Neuromolecular Medicine. 2: 271-80. PMID 12622405 DOI: 10.1385/NMM:2:3:271  0.32
2002 Planells-Cases R, Montoliu C, Humet M, Fernández AM, García-Martínez C, Valera E, Merino JM, Pérez-Payá E, Messeguer A, Felipo V, Ferrer-Montiel A. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity. The Journal of Pharmacology and Experimental Therapeutics. 302: 163-73. PMID 12065713  0.32
2002 Montoliu C, Humet M, Canales JJ, Burda J, Planells-Cases R, Sánchez-Baeza F, Carbonell T, Pérez-Payá E, Messeguer A, Ferrer-Montiel A, Felipo V. Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants. The Journal of Pharmacology and Experimental Therapeutics. 301: 29-36. PMID 11907154 DOI: 10.1124/jpet.301.1.29  0.32
2002 García-Martinez C, Humet M, Planells-Cases R, Gomis A, Caprini M, Viana F, De La Pena E, Sanchez-Baeza F, Carbonell T, De Felipe C, Pérez-Paya E, Belmonte C, Messeguer A, Ferrer-Montiel A. Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proceedings of the National Academy of Sciences of the United States of America. 99: 2374-9. PMID 11854530 DOI: 10.1073/pnas.022285899  0.32
Show low-probability matches.